DecisionPoint Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
DecisionPoint Financial's BMY Position: Q3 2026 in Review
DecisionPoint Financial increased its Bristol-Myers Squibb (BMY) stake by 4,992% in Q3 2026, buying an estimated $75.7K and bringing the position to 1,222 shares worth $75.1K. The position accounts for 0.01% of the portfolio, ranked #115.
DecisionPoint Financial first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $108K in Q4 2022. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- DecisionPoint Financial held 1,222 shares of Bristol-Myers Squibb worth $75.1K as of Q3 2026.
- DecisionPoint Financial bought 1,198 Bristol-Myers Squibb shares in Q3 2026, an estimated $75.7K.
- Bristol-Myers Squibb made up 0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #115 holding.
- DecisionPoint Financial first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
- DecisionPoint Financial's Bristol-Myers Squibb position peaked at $108K in Q4 2022.
- 907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.